Launa J. Aspeslet

Nessuna posizione attualmente

Health Technology

Consumer Services

Profilo

Launa J.
Aspeslet served as the Chief Executive Officer at Translational Research In Oncology from 2015 to 2022.
Prior to that, she was the Chief Operating Officer & Head-Investor Relations at Isotechnika Pharma, Inc. from 2009 to 2013.
She also held the position of Chief Operating Officer at Aurinia Pharmaceuticals, Inc. Additionally, she is currently serving as the Chief Operating Officer at Hepion Pharmaceuticals, Inc. starting from 2022.
Dr. Aspeslet holds a doctorate degree from the University of Alberta, which she obtained in 1994.
She also completed her undergraduate studies at the University of Lethbridge in 1989.

Precedenti posizioni note di Launa J. Aspeslet

Società	Posizione	Fine
HEPION PHARMACEUTICALS, INC.	Chief Operating Officer	01/01/2024
Translational Research In Oncology	Chief Executive Officer	01/05/2022
Isotechnika Pharma, Inc. Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada.	Chief Operating Officer	23/10/2013
AURINIA PHARMACEUTICALS INC.	Chief Operating Officer	-

Vedi nel dettaglio l'esperienza di Launa J. Aspeslet

Formazione di Launa J. Aspeslet

University of Alberta	Doctorate Degree
University of Lethbridge	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Launa J. Aspeslet

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
HEPION PHARMACEUTICALS, INC.	Health Technology
AURINIA PHARMACEUTICALS INC.	Health Technology

Aziende private	2
Isotechnika Pharma, Inc. Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada.	Health Technology
Translational Research In Oncology